Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this focused activity, Jennifer Woyach, MD; Nichole Fisher, RN, BSN; and Anthony Perissinotti, PharmD, BCOP, discuss the latest information on measurable residual disease (MRD) testing and its clinical use in the care of patients with chronic lymphocytic leukemia (CLL).
Clinical Care Options plans to measure the educational impact of this activity, and some questions in this activity will be asked twice: once before the discussion that informs the best choice and then again after that specific discussion. Your responses will be aggregated for analysis, but your specific responses will not be shared.
Before continuing with this educational activity, please take a moment to answer the following question.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
